DGE:LSEDiageo plc Analysis
Data as of 2026-03-10 - not real-time
£1,521.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Diageo’s share price of 1,521 p sits well below its 20‑day (1,710.5 p) and 50‑day (1,680.1 p) moving averages, signaling a technical lag, while the RSI of 35 points to oversold conditions. The bearish MACD and a widening gap to the 200‑day SMA (1,813.3 p) reinforce short‑term downside pressure, yet the upside potential of ~30 % (median target ~1,979 p) and a forward PE of 12.5× suggest a meaningful re‑rating upside.
Recent news adds nuance: a sudden Crown Royal plant closure and a revised forecast have hammered sentiment, but the appointment of a new CEO with an executive overhaul plan is being priced in by analysts, who maintain a “buy” consensus. The high dividend yield of 4.1 % is attractive, but a payout ratio near 95 % and a debt‑to‑equity of 177 × raise questions about dividend sustainability and balance‑sheet resilience.
Recent news adds nuance: a sudden Crown Royal plant closure and a revised forecast have hammered sentiment, but the appointment of a new CEO with an executive overhaul plan is being priced in by analysts, who maintain a “buy” consensus. The high dividend yield of 4.1 % is attractive, but a payout ratio near 95 % and a debt‑to‑equity of 177 × raise questions about dividend sustainability and balance‑sheet resilience.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI indicating potential bounce
- Bearish MACD and price below short‑term SMAs
- High dividend yield offset by sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 30 % upside to analyst price targets
- Forward PE of 12.5× suggesting earnings‑driven re‑rating
- Management turnover and turnaround plan
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong global brand portfolio and cash‑flow generation
- Attractive dividend yield for income‑focused investors
- Long‑term growth opportunities in emerging markets
Key Metrics & Analysis
Financial Health
Revenue Growth-4.00%
Profit Margin12.19%
P/E Ratio18.8
ROE19.72%
ROA7.21%
Debt/Equity177.38
P/B Ratio387.6
Op. Cash Flow£4.1B
Free Cash Flow£958.1M
Technical Analysis
TrendNeutral
RSI35.2
Support£1,491.00
Resistance£1,903.91
MA 20£1,710.50
MA 50£1,680.09
MA 200£1,813.30
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target Price£1,968.12
Upside/Downside29.40%
GradeUndervalued
TypeBlend
Dividend Yield4.11%
Risk Assessment
Beta0.07
Volatility52.40%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.